Page last updated: 2024-10-22

amantadine and Poliomyelitis

amantadine has been researched along with Poliomyelitis in 3 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Poliomyelitis: An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campagnola, G1
Gong, P1
Peersen, OB1
Hirschman, SZ1
Bauer, DJ1

Reviews

2 reviews available for amantadine and Poliomyelitis

ArticleYear
Approaches to antiviral chemotherapy.
    The American journal of medicine, 1971, Volume: 51, Issue:6

    Topics: Amantadine; Animals; Antiviral Agents; Benzimidazoles; Culture Techniques; Cytarabine; DNA Nucleotid

1971
Antiviral chemotherapy.
    Modern trends in medical virology, 1967, Volume: 1, Issue:0

    Topics: Adult; Amantadine; Animals; Antiviral Agents; Benzimidazoles; Child, Preschool; Common Cold; Female;

1967

Other Studies

1 other study available for amantadine and Poliomyelitis

ArticleYear
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
    Antiviral research, 2011, Volume: 91, Issue:3

    Topics: Allosteric Regulation; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; F

2011